David Malcom Rodman - 12 Feb 2025 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role: Chief Medical Officer
Signature: /s/ Adam Levy, Attorney-in-fact
Issuer symbol: MLYS
Transactions as of: 12 Feb 2025
Net transactions value: +$6,856
Form type: 4
Filing time: 13 Feb 2025, 17:29:35 UTC
Previous filing: 15 Jan 2025
Next filing: 24 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MLYS	Common Stock	Options Exercise	$6,856	+6,348	+4%	$1.08	164,520	12 Feb 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MLYS	Stock Option	Options Exercise	$0	-6,348	-4.9%	$0.000000	122,229	12 Feb 2025	Common Stock	6,348	$1.08	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option vested with respect to 25% of the underlying shares on July 12, 2022, and vests with respect to the remaining shares in 36 substantially equal monthly installments thereafter.